9 / 9
Volume 3
Current Research: Integrative Medicine
Nursing Care & ICNND 2018
October 22-23, 2018
Page 29
Notes:
Nursing Care, Neurology and Neuromuscular Diseases
October 22-23, 2018 Madrid, Spain
46
th
World Congress on
Combined treatment of spine tumors
E
very year in the US 180,000 new cases are diagnosed and 20,000 of them with medullar compression. 5-14% of patients
with cancer develop spine metastases, from them 33% bone, 4% leptomeningeal, 0.1-0.4% intramedullary. Of those with
spinal metastases, 60% had breast, lung or prostate cancer. The treatment basically is based on surgery, radiotherapy combined
treatment and radiosurgery. Until 1990 the first treatment was radiotherapy, later, surgery was practiced. Patchel trial
demonstrated the superiority of surgery (Lancet 2005), Class I evidence. From then, NOMS and SINS criteria was considered.
The development of technology in radiotherapy makes us to change the paradigm. Radiosurgery take a very important role
in the treatment of spine tumors. The combined treatment is our first option, surgery + radiosurgery. The principal indication
of spine radiosurgery as a primary treatment are residual tumors after surgery, recurrent tumors, multiple lesion, unfarmable
localization, high risk for open surgery.
Biography
Kita Sallabanda Diaz is currently working as an Associate Professor at the Complutense University of Madrid, a Tutor for residents of the San Carlos Clinical Hospital
in Madrid and is a Professor of the International Master's degree in Advanced Technological Applications in Radiation Oncology. He is also working at the Genesiscare
Madrid-Arturo Soria, while he is an External Medical Consultant at the San Carlos University Clinical Hospital in Madrid. He is the current President of the Spanish Society
of Radiosurgery and the Neuro-Oncology Committee of the Clinical Hospital of Madrid. His areas of expertise are mainly in cyber knife SRS, epilepsy, cognitive functions
and brain metastases.
ksallabanda@gmail.comKita Sallabanda Diaz
Complutense University of Madrid, Spain
Kita Sallabanda Diaz, J Current Res: Int Medicine 2018, Volume 3
DOI: 10.4172/2529-797X-C2-004